Shares Of Small-Cap Company Perk Higher On New Cannabis Cultivation License

Sponsored:

Monday, March 10, 2025

As the cannabis industry expands across the U.S., its financial impact continues to grow. Today, a small-cap company is making waves in one of the newest states to legalize medical cannabis.

Shares of Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) are on the move higher as the company, an industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, announced this morning its management services agreement with a Tier 3 Cultivation License in Kentucky. 

The agreement entitles Cresco Labs to manage and operate a cultivation facility with up to 25,000 square feet of canopy, marking a significant milestone for the Company and establishing Cresco Labs as one of only two operators of Kentucky’s coveted Tier 3 cultivation licenses.

Kentucky’s medical cannabis program, launched on January 1, 2025, represents a significant milestone for the state. The program includes a maximum of 115,000 square feet of approved canopy space and 48 retail licenses, with industry analysts forecasting the market to generate over $135 million in revenue by 2026, growing to over $228 million by 2028 1 . The Cultivation License positions the Company at the forefront of this burgeoning market, with the opportunity to shape its growth and success.

Charlie Bachtell, CEO of Cresco Labs commented in the press release, “We’ve spent the last two years focused on solidifying the core and increasing our free cash flow. Kentucky is our first of many opportunities to reinvest that free cash flow back into high ROIC growth initiatives as we continue expanding into new markets.”

On an otherwise ugly day on the markets, shares of CL appear to be holding their own, trading even on the day at $1.09 while U.S. listed shares have ticked up by $0.01 to $0.768 in mid-morning trading.

Sponsored: